Trial intelligence / Profile preview

Gabapentin for Post-Tonsillectomy Pain in Adolescents

NCT05024825Phase 4Terminated

Sponsor
Albany Medical College
Start
Aug 2017
Primary completion
May 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of gabapentin in pain (2 arms), sponsored by Albany Medical College. Primary endpoint: Total opioid equivalent dose at 7 days. Started Aug 2017; status: terminated.

02

Drugs

gabapentin
03

Conditions

pain

Beyond the preview

Go deeper on NCT05024825.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05024825.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call